{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:43:59Z","timestamp":1788918239227,"version":"build-2803163510"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Tertiary lymphoid structures (TLSs) are lymphoid cell clusters that form in non-lymphoid tissues in response to chronic inflammation and function as sites for localized, antigen-specific immune responses, potentially enhancing anti-tumor immunity. This review examines TLS presence, composition, and clinical significance across genitourinary (GU) cancers to evaluate their potential as prognostic and therapeutic targets. In prostate cancer, TLSs are infrequently found due to a typically immunologically inactive tumor microenvironment (TME), but when present, they correlate with improved outcomes and reduced recurrence, especially when structurally mature with active germinal centers (GCs). Bladder cancer, in contrast, demonstrates increased TLS activity, particularly in high-grade disease, with high TLS density associated with superior responses to Bacillus Calmette-Gu\u00e9rin (BCG) therapy and anti-PD-L1 treatment. In testicular seminomas, TLSs have been associated with a more favorable prognosis, whereas non-seminomatous germ cell tumors demonstrate TLS suppression driven by SERPINB9-mediated downregulation of chemokines that promote their development. In clear cell renal cell carcinoma (ccRCC), TLSs correlate with improved survival and enhanced immunotherapy responses, although elevated\n                    <jats:italic>CXCL13<\/jats:italic>\n                    expression may paradoxically signal more aggressive disease. Unlike ccRCC, TLSs are infrequent in papillary and chromophobe RCC, reflecting a less-inflamed TME that likely contributes to reduced immunotherapy responsiveness and prognostic value. TLSs in penile squamous cell carcinomas show enhanced immune infiltration and improved overall survival (OS) independent of stage. Notably, mature TLSs are key for effective anti-tumor immunity, whereas immature TLSs may fail to generate an adequate response. Collectively, these findings highlight TLSs as prognostic biomarkers with prognostic value and therapeutic potential in GU malignancies.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1787200","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:32:33Z","timestamp":1771997553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Tertiary lymphoid structures in genitourinary cancers: a comprehensive review"],"prefix":"10.3389","volume":"16","author":[{"given":"Alvaro","family":"Abreu","sequence":"first","affiliation":[{"name":"Herbert Wertheim College of Medicine, Florida International University","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Viera Plasencia","sequence":"additional","affiliation":[{"name":"Herbert Wertheim College of Medicine, Florida International University","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Iribarren","sequence":"additional","affiliation":[{"name":"Herbert Wertheim College of Medicine, Florida International University","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Wegner","sequence":"additional","affiliation":[{"name":"Herbert Wertheim College of Medicine, Florida International University","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Nuraj","sequence":"additional","affiliation":[{"name":"Herbert Wertheim College of Medicine, Florida International University","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[{"name":"Veracyte, Inc.","place":["South San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham F.","family":"Bahmad","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine","place":["Miami, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shahait","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Irvine","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000532127","article-title":"Urological tumor: A narrative review of tertiary lymphatic structures","volume":"107","author":"Shen","year":"2023","journal-title":"Urol Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.793964","article-title":"The tumor immune landscape and architecture of tertiary lymphoid structures in urothelial cancer","volume":"12","author":"Van Dijk","year":"2021","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1002\/iid3.70003","article-title":"The relationship between the tertiary lymphoid structure and immune-infiltrating cells in gastrointestinal cancers: A systematic review and meta-analysis","volume":"12","author":"Yu","year":"2024","journal-title":"Immunity Inflammation Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.03.002","article-title":"Adaptive immunity in genitourinary cancers","volume":"6","author":"Koti","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1147480","article-title":"Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry","volume":"14","author":"Le Rochais","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0256907","DOI":"10.1371\/journal.pone.0256907","article-title":"Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer","volume":"16","author":"Barmpoutis","year":"2021","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100063","DOI":"10.1016\/j.labinv.2023.100063","article-title":"Standardized pathology screening of mature tertiary lymphoid structures in cancers","volume":"103","author":"Vanhersecke","year":"2023","journal-title":"Lab Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-8709-2_4","article-title":"Development of tools for the selective visualization and quantification of TLS-immune cells on tissue sections","volume":"1845","author":"Klein","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.3142","article-title":"A digital imaging analysis (DIA) platform for identifying tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD)","volume":"40","author":"Kushnarev","year":"2022","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2252553","DOI":"10.1001\/jamanetworkopen.2022.52553","article-title":"Development and validation of a machine learning model for detection and classification of tertiary lymphoid structures in gastrointestinal cancers","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Network Open"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00767","article-title":"Tumor-associated tertiary lymphoid structures: gene-expression profiling and their bioengineering","volume":"8","author":"Zhu","year":"2017","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"217491","DOI":"10.1016\/j.canlet.2025.217491","article-title":"Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application","volume":"613","author":"Cui","year":"2025","journal-title":"Cancer Lett"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2410998","DOI":"10.1002\/advs.202410998","article-title":"Tertiary lymphoid structures are linked to enhanced antitumor immunity and better prognosis in muscle-invasive bladder cancer","volume":"12","author":"Lin","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1096220","article-title":"Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma","volume":"14","author":"Liang","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2024.07.020","article-title":"Tertiary lymphoid structure in tumor microenvironment and immunotherapy of lung cancer","volume":"60","author":"Xie","year":"2024","journal-title":"Archivos Bronconeumolog\u00eda"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1369626","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.652747","article-title":"Tumor microenvironment in prostate cancer: toward identification of novel molecular biomarkers for diagnosis, prognosis, and therapy development","volume":"12","author":"Abou-Kheir","year":"2021","journal-title":"Front Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00563","article-title":"A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression","volume":"8","author":"Garc\u00eda-Hern\u00e1ndez","year":"2017","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24684","article-title":"Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer","volume":"84","author":"Shahait","year":"2024","journal-title":"Prostate"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.05.010","article-title":"Prostate cancer in the arab world: A view from the inside","volume":"13","author":"Lara Hilal","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000541881","article-title":"The immune microenvironment in prostate cancer: A comprehensive review","volume":"103","author":"Novysedlak","year":"2024","journal-title":"Oncology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.260","article-title":"The unexpected role of lymphotoxin \u03b2 receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development","volume":"29","author":"Wolf","year":"2010","journal-title":"Oncogene"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.02.016","article-title":"Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2","volume":"1864","author":"Tsai","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082309","article-title":"Epithelial-to-mesenchymal transition-related markers in prostate cancer: from bench to bedside","volume":"15","author":"Gogola","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2023092","article-title":"Advances in landscape and related therapeutic targets of the prostate tumor microenvironment","volume":"55","author":"Li","year":"2023","journal-title":"Acta Biochim Biophys Sin"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2018.10.011","article-title":"The requirement for immune infiltration and organization in the tumor microenvironment for successful immunotherapy in prostate cancer","volume":"37","author":"Jansen","year":"2019","journal-title":"Urologic Oncol Semin Original Investigations"},{"key":"B32","doi-asserted-by":"publisher","first-page":"450.e413","DOI":"10.1016\/j.urolonc.2024.06.010","article-title":"Prognostic and predictive value of tertiary lymphoid structures in TURBT materials: Should it be seated in the routine pathological examination, and can it be used in deciding on the treatment method","volume":"42","author":"Yilmaz","year":"2024","journal-title":"Urol Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.793992","article-title":"Molecular, immunological, and clinical features associated with lymphoid neogenesis in muscle invasive bladder cancer","volume":"12","author":"Pagliarulo","year":"2022","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.01.036","article-title":"Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy","volume":"148","author":"Groeneveld","year":"2021","journal-title":"Eur J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2025.09.056","article-title":"The clinical relevance of tertiary lymphoid structures in assessing treatment response in muscle-invasive bladder cancer","volume":"124","author":"Hassan","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-024-04860-1","article-title":"Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer","volume":"22","author":"Yuan","year":"2024","journal-title":"J Trans Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad283","article-title":"Presence, subtypes, and prognostic significance of tertiary lymphoid structures in urothelial carcinoma of the bladder","volume":"29","author":"Ma","year":"2023","journal-title":"Oncologist"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s43856-023-00421-7","article-title":"Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors","volume":"4","author":"Van Rijthoven","year":"2024","journal-title":"Commun Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1049884","article-title":"Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer","volume":"13","author":"An","year":"2022","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13293-022-00428-0","article-title":"Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer","volume":"13","author":"Hamade","year":"2022","journal-title":"Biol Sex Differ"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003196","article-title":"Bladder mucosal cystitis cystica lesions are tertiary lymphoid tissues that correlate with recurrent urinary tract infection frequency in postmenopausal women","volume":"209","author":"Ligon","year":"2023","journal-title":"J Urol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/cac2.12491","article-title":"Spatial relationship of tertiary lymphoid structures and tumor-associated neutrophils in bladder cancer and prognostic potential for anti-PD-L1 immunotherapy","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.6_suppl.528","article-title":"Biomarker analysis and updated clinical follow-up from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy","volume":"40","author":"Gupta","year":"2022","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02598-7","article-title":"Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer","volume":"130","author":"Zhang","year":"2024","journal-title":"Br J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1085-z","article-title":"Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial","volume":"26","author":"Van Dijk","year":"2020","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma","volume":"26","author":"Gao","year":"2020","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"LBA4517","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA4517","article-title":"Perioperative sacituzumab govitecan (SG) alone or in combination with pembrolizumab (Pembro) for patients with muscle-invasive urothelial bladder cancer (MIBC): SURE-01\/02 interim results","volume":"42","author":"Cigliola","year":"2024","journal-title":"J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00576","article-title":"First results of NURE-combo: A phase II study of neoadjuvant nivolumab and nab-paclitaxel, followed by postsurgical adjuvant nivolumab, for muscle-invasive bladder cancer","volume":"42","author":"Mercinelli","year":"2024","journal-title":"J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.4594","article-title":"Overall survival and biomarker results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC)","volume":"43","author":"Mercinelli","year":"2025","journal-title":"J Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.4518","article-title":"First results of SURE-02: A phase 2 study of neoadjuvant sacituzumab govitecan (SG) plus pembrolizumab (Pembro), followed by response-adapted bladder sparing and adjuvant pembro, in patients with muscle-invasive bladder cancer (MIBC)","volume":"43","author":"Necchi","year":"2025","journal-title":"J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1038\/s41467-025-63514-y","article-title":"Chronic inflammation drives epididymal tertiary lymphoid structure formation and autoimmune fertility disorders in mice","volume":"16","author":"Elizagaray","year":"2025","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1106434","article-title":"Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures","volume":"13","author":"Magara","year":"2023","journal-title":"Front Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41419-024-07220-5","article-title":"Single-cell landscape identified SERPINB9 as a key player contributing to stemness and metastasis in non-seminomas","volume":"15","author":"Bian","year":"2024","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03123-y","article-title":"Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma","volume":"71","author":"Xu","year":"2022","journal-title":"Cancer Immunology Immunotherapy"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1616904","article-title":"The pivotal role of tertiary lymphoid structures in the tumor immune microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"100558","DOI":"10.1016\/j.modpat.2024.100558","article-title":"Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue","volume":"37","author":"Sobottka","year":"2024","journal-title":"Modern Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12894-024-01532-6","article-title":"A model of tertiary lymphatic structure-related prognosis for penile squamous cell carcinoma","volume":"24","author":"Tang","year":"2024","journal-title":"BMC Urol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e70059","DOI":"10.1002\/2056-4538.70059","article-title":"B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma","volume":"11","author":"Zavillov\u00e1","year":"2025","journal-title":"J Pathol Clin Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2023.03.010","article-title":"Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases","volume":"55","author":"Hrudka","year":"2023","journal-title":"Pathology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e09742","DOI":"10.1002\/advs.202509742","article-title":"Spatial transcriptional dynamics of CD74+ B cells in tertiary lymphoid structures drive immune evolution in penile squamous cell carcinoma","volume":"12","author":"Xue","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01694.x","article-title":"Clinical usage of the squamous cell carcinoma antigen in patients with penile cancer","volume":"14","author":"Touloupidis","year":"2007","journal-title":"Int J Urol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12885-019-5714-1","article-title":"Prognostic value of lymphovascular invasion in patients with squamous cell carcinoma of the penis following surgery","volume":"19","author":"Li","year":"2019","journal-title":"BMC Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ol.2023.13674","article-title":"Venous thrombosis, multiple carcinomatous foci and differences in metastatic pathways of penile carcinoma","volume":"25","author":"Yi","year":"2023","journal-title":"Oncol Lett"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062785","article-title":"Inflammation in penile squamous cell carcinoma: A comprehensive review","volume":"26","author":"Czajkowski","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1038\/s41598-025-89760-0","article-title":"Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma","volume":"15","author":"Miyagi","year":"2025","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1463445","article-title":"Human papillomavirus infection affects the immune microenvironment and antigen presentation in penile cancer","volume":"14","author":"Guimar\u00e3es","year":"2024","journal-title":"Front Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568825","article-title":"Neutrophil-to-lymphocyte ratio predicts a poor prognosis for penile cancer with an immunosuppressive tumor microenvironment","volume":"16","author":"Tan","year":"2025","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"107099","DOI":"10.1016\/j.imlet.2025.107099","article-title":"CD4 and CD8 T-cell lymphocytes from penile squamous cell carcinoma tumors are more differentiated with higher PD-1 expression compared to lymphocytes in peripheral circulation","volume":"277","author":"Mumba","year":"2026","journal-title":"Immunol Lett"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020303","article-title":"Multiplex immunofluorescence captures progressive immune exhaustion with advancing penile squamous cell cancer stage","volume":"16","author":"Ionescu","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.6_suppl.12","article-title":"Differential expression of PDL-1 and tumour-associated macrophages in N0 and N+ penile cancer","volume":"41","author":"Azhar","year":"2023","journal-title":"J Clin Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01253","article-title":"The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma","volume":"9","author":"Ottenhof","year":"2018","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00617-x","article-title":"Immune-based therapies in penile cancer","volume":"19","author":"Joshi","year":"2022","journal-title":"Nat Rev Urol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055235","article-title":"Immune landscape and immunotherapy for penile cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212142","article-title":"Gene expression profiling of the peritumoral immune cell infiltrate of penile squamous cell carcinomas","volume":"25","author":"Winkelmann","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41698-024-00579-w","article-title":"Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response","volume":"8","author":"Chen","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"218059","DOI":"10.1016\/j.canlet.2025.218059","article-title":"AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma","volume":"634","author":"Hammouda","year":"2025","journal-title":"Cancer Lett"},{"key":"B78","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.4_suppl.691","article-title":"Correlation of artificial intelligence (AI)-based spatial characteristics of tumor-infiltrating lymphocytes outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial cancer (mUC)","volume-title":"2024 ASCO genitourinary cancers symposium","author":"Hammouda","year":"2024"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.7150\/thno.113940","article-title":"Dissecting tertiary lymphoid structures in cancer: maturation, localization and density","volume":"15","author":"Su","year":"2025","journal-title":"Theranostics"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01830","article-title":"Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease","volume":"8","author":"Colbeck","year":"2017","journal-title":"Front Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1787200\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:32:34Z","timestamp":1771997554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1787200\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":82,"alternative-id":["10.3389\/fonc.2026.1787200"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1787200","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1787200"}}